29 related articles for article (PubMed ID: 9225789)
1. Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis.
Painter RG; Lanson NA; Jin Z; Park F; Wang G
Cancer Sci; 2005 Sep; 96(9):607-13. PubMed ID: 16128746
[TBL] [Abstract][Full Text] [Related]
2. Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells.
McNeish IA; Tenev T; Bell S; Marani M; Vassaux G; Lemoine N
Cancer Gene Ther; 2024 Jun; 31(6):955. PubMed ID: 38698243
[No Abstract] [Full Text] [Related]
3. Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control.
Lu L; Xie M; Yang B; Zhao WB; Cao J
Sci Adv; 2024 Feb; 10(8):eadj6251. PubMed ID: 38394207
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.
Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG
ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.
Yaghoubi SS; Campbell DO; Radu CG; Czernin J
Theranostics; 2012; 2(4):374-91. PubMed ID: 22509201
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy imaging in patients for oncological applications.
Peñuelas I; Haberkorn U; Yaghoubi S; Gambhir SS
Eur J Nucl Med Mol Imaging; 2005 Dec; 32 Suppl 2():S384-403. PubMed ID: 16180032
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography (PET): expanding the horizons of oncology drug development.
Hammond LA; Denis L; Salman U; Jerabek P; Thomas CR; Kuhn JG
Invest New Drugs; 2003 Aug; 21(3):309-40. PubMed ID: 14578681
[TBL] [Abstract][Full Text] [Related]
8. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.
Fillat C; Carrió M; Cascante A; Sangro B
Curr Gene Ther; 2003 Feb; 3(1):13-26. PubMed ID: 12553532
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of suicide genes for the treatment of malignant gliomas: efficacy, limitations, and perspectives for a combined immunotherapy.
Benedetti S; Di Meco F; Pollo B; Bruzzone MG; Cirenei N; Spreafico R; Solero CL; Broggi G; Di Donato S; Finocchiaro G
Acta Neurochir Suppl; 1997; 68():100-4. PubMed ID: 9233423
[TBL] [Abstract][Full Text] [Related]
10. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.
Haberkorn U; Altmann A; Morr I; Germann C; Oberdorfer F; van Kaick G
J Nucl Med; 1997 Jul; 38(7):1048-54. PubMed ID: 9225789
[TBL] [Abstract][Full Text] [Related]
11. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.
Haberkorn U; Altmann A; Morr I; Knopf KW; Germann C; Haeckel R; Oberdorfer F; van Kaick G
J Nucl Med; 1997 Feb; 38(2):287-94. PubMed ID: 9025757
[TBL] [Abstract][Full Text] [Related]
12. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.
Haberkorn U; Altmann A; Kamencic H; Morr I; Traut U; Henze M; Jiang S; Metz J; Kinscherf R
Eur J Nucl Med; 2001 Nov; 28(11):1690-6. PubMed ID: 11702112
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase.
Haberkorn U; Bellemann ME; Gerlach L; Morr I; Trojan H; Brix G; Altmann A; Doll J; van Kaick G
Gene Ther; 1998 Jul; 5(7):880-7. PubMed ID: 9813658
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
Germann C; Shields AF; Grierson JR; Morr I; Haberkorn U
J Nucl Med; 1998 Aug; 39(8):1418-23. PubMed ID: 9708520
[TBL] [Abstract][Full Text] [Related]
15. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
